R&D and Procurement Collaboration: 7 Powerful Ways to Avoid Costly Delays
R&D and procurement collaboration is essential when developing new formulations, qualifying raw materials, and preparing products for commercial production. Yet in many manufacturing businesses, these functions still work toward different priorities. R&D focuses on technical performance, while procurement focuses on price, lead time, minimum order quantity (MOQ), and supply reliability.
Both perspectives are necessary. The problem begins when they are considered separately rather than as parts of the same sourcing and development process.
A technically promising ingredient may be unsuitable for commercial purchasing because its MOQ is too high, its lead time is unpredictable, or its supply source cannot meet the project’s documentation requirements. Conversely, a competitively priced alternative may fail application testing, require formulation changes, or introduce variability that creates additional work for R&D.
These situations are not simply communication problems. They are process problems that can delay product development, increase evaluation costs, and complicate the transition from laboratory samples to commercial production.
Why R&D and Procurement Collaboration Matters
R&D and procurement often evaluate the same ingredient using different criteria.
For R&D, the central questions concern functionality, compatibility, solubility, particle size, stability, sensory characteristics, and performance within the intended formulation. For procurement, the questions concern availability, price, MOQ, lead time, supplier capability, documentation, and continuity of supply.
Neither set of criteria is sufficient on its own.
An ingredient that performs exceptionally well in a laboratory may be difficult to source consistently at the required commercial volume. A readily available material may meet the purchasing budget but perform differently in the actual formulation. If these constraints are discovered late, the team may have to repeat testing, revise specifications, or restart supplier qualification.
The American Society for Quality (ASQ) identifies cross-functional participation as an important element of supplier selection. Its guidance emphasizes evaluating suppliers against factors that extend beyond purchase price, including quality, delivery, technical support, and total cost. See the ASQ Supplier Quality resource.
The practical lesson is straightforward: ingredient sourcing should begin with shared requirements, not a specification handed from one department to another after the key decisions have already been made.
7 Ways to Improve R&D and Procurement Collaboration
1. Define the Application Before Searching for Ingredients
The first step is to establish what the ingredient must actually do.
A request such as “find a suitable botanical extract” provides too little information for effective sourcing. R&D should clarify the intended application, required active content or standardization, dosage form, particle size, solubility, sensory requirements, and any relevant stability or compatibility considerations.
Procurement should add the commercial constraints early: target cost, expected annual demand, initial evaluation quantity, preferred lead time, destination market, and required supplier documentation.
Not every parameter needs to be finalized before the search begins. However, the team should distinguish mandatory requirements from preferences that can be adjusted.
For example, a specific particle size may be essential for a powder’s processing performance, while packaging format or an initial order quantity may offer more flexibility. Making this distinction helps suppliers identify realistic options without compromising the formulation’s critical requirements.
2. Separate Non-Negotiable Specifications From Flexible Parameters
A common source of conflict is treating every specification as equally important.
R&D may request an ideal specification based on laboratory performance, while procurement discovers that the combination of grade, MOQ, price, and lead time significantly narrows the available supply options.
Rather than asking one department to abandon its priorities, the team should classify requirements into three groups: critical acceptance criteria, preferred technical or commercial parameters, and variables open to evaluation.
Critical criteria might include ingredient identity, a minimum assay, defined contaminant limits, or a performance requirement established through testing. Flexible parameters might include a packaging configuration, a sourcing route, or a specification range that can be changed without compromising product quality.
Any proposed change to a critical requirement should return to the appropriate technical and quality stakeholders for review. A lower price is not a valid reason to relax a specification without evidence that the alternative remains suitable.
This shared framework gives suppliers clearer instructions and helps prevent repeated quotation and sampling cycles.
3. Evaluate Suppliers Before Finalizing the Formulation
Supplier qualification should not be postponed until R&D has completed its evaluation.
At the early sourcing stage, procurement can assess whether potential suppliers can support the required quantity, lead time, documentation, and expected demand. R&D can evaluate whether the available grades and technical information are relevant to the intended application.
Quality or regulatory colleagues may also need to review specifications, certificates of analysis, manufacturing information, and market-specific requirements.
This does not mean that every supplier must complete a full audit before an initial sample is requested. The depth of qualification should reflect the material, application, risk, and applicable requirements.
The goal is to identify major supply constraints before the team invests heavily in testing a material that cannot realistically support the project.
4. Compare Samples Against Both Technical and Commercial Criteria
A successful sample evaluation should answer two different questions: does the ingredient work, and can it support the intended purchasing plan?
R&D should evaluate samples against predefined criteria under relevant application conditions. Depending on the formulation, this may include solubility, dispersion, processing behavior, sensory properties, compatibility, stability, or finished-product performance.
Procurement should simultaneously verify the commercial details behind the sample: the grade being offered, available batch documentation, MOQ, quotation validity, lead time, and whether the quoted material corresponds to the material evaluated.
A sample that performs well but comes from a different grade or an unconfirmed source may not provide a reliable basis for a bulk purchasing decision.
Recording the sample identity, batch reference where available, test conditions, acceptance criteria, and results creates a more useful basis for subsequent decisions. It also makes disagreements easier to resolve because the discussion can return to evidence rather than assumptions.
5. Assess Total Cost, Not Just the Price Per Kilogram
A lower unit price does not necessarily produce a lower project cost.
The relevant comparison may include sample expenses, laboratory testing, formulation rework, minimum order commitments, freight, storage, incoming quality checks, rejected material, and the cost of delays.
For example, a material with a lower quoted price may require a much larger initial order than the project needs. If the team is still validating the formulation, that purchase could create unnecessary inventory exposure. A more flexible MOQ may be commercially preferable during early development, even if the unit price is higher.
The opposite can also be true. A higher-priced ingredient may be justified if it reduces processing difficulties, improves reproducibility, or provides a more reliable supply arrangement.
Procurement and R&D should therefore compare viable options using a shared assessment of technical suitability, total cost, supply risk, and expected demand. The objective is not to select the cheapest material or the most technically impressive material in isolation. It is to select an option that meets the product’s requirements and can be sourced responsibly.
6. Plan the Transition From Sample to Pilot and Bulk Supply
Passing a laboratory evaluation does not automatically establish readiness for commercial production.
The material used for initial testing may differ in batch size, manufacturing conditions, packaging, or source from the material eventually supplied in bulk. Those differences may or may not affect performance, but they should be assessed rather than assumed to be irrelevant.
Before scaling up, the team should confirm the approved specification, supplier and grade, relevant documentation, expected order quantities, lead times, and the process for handling material or specification changes.
Where appropriate, pilot-scale testing can help determine whether the ingredient behaves consistently under more representative processing conditions. Quality and procurement teams should also establish how batch records, deviations, and supplier changes will be reviewed.
This staged approach helps connect laboratory success with purchasing decisions and production requirements. It also makes it easier to identify what needs to be confirmed before a larger commercial commitment is made.
7. Establish One Shared Process From Inquiry to Commercial Supply
The final improvement is organizational: give R&D, procurement, and quality a common view of the project’s status.
A practical workflow can include requirement definition, supplier screening, document review, sample evaluation, technical approval, commercial confirmation, pilot validation, and bulk purchasing.
At each stage, the team should know who owns the decision, which evidence is required, and what must be resolved before proceeding.
For example, R&D may own technical acceptance, procurement may own commercial evaluation and supplier coordination, and quality may review documentation and qualification requirements. These responsibilities can differ by organization, but the handoffs should be explicit.
A shared record of specifications, quotations, sample results, approved suppliers, and outstanding questions reduces the risk of different departments working from outdated information.
The NIST publication on concurrent engineering discusses the integration of people, systems, and information in product development. Although the publication is not specific to ingredient sourcing, the underlying principle is relevant: decisions become more efficient when the information needed by different functions is connected throughout the development process.
From Ingredient Supplier to Sourcing Partner
Effective R&D and procurement collaboration does not require both departments to become experts in each other’s work. It requires a process that connects their different priorities early enough to influence the outcome.
R&D needs ingredients that perform under real application conditions. Procurement needs materials that can be purchased at workable quantities, prices, and lead times. Quality teams need appropriate evidence that the material meets established requirements. Commercial production needs a supply arrangement that can support demand without introducing avoidable uncertainty.
An effective sourcing partner can help connect these requirements by clarifying specifications, identifying suitable supply options, coordinating samples, providing available documentation, and discussing the practical path from initial evaluation to larger orders.
At Esubio, our approach is built around flexible sourcing support for functional ingredients and specialty raw materials, with a focus on low MOQ, fast sampling, and reliable international supply. Our product scope includes botanical extracts, amino acids, vitamins, probiotics and postbiotics, fruit and vegetable powders, functional ingredients, and selected specialty excipients.
For projects with specific application, specification, quantity, or documentation requirements, early communication helps us assess suitable sourcing options and clarify what can be supported before the project advances.
The objective is not to replace the expertise of R&D or procurement. It is to help both functions work from the same requirements, evaluate realistic options, and make better-informed decisions throughout the sourcing process.
When technical feasibility and commercial feasibility are considered together, sourcing becomes more than a transaction. It becomes a coordinated process that helps move a project from an initial idea toward a validated formulation and a workable supply plan.
Working on a new formulation or a difficult-to-source ingredient? Contact Esubio to discuss your technical requirements, evaluation quantities, target specifications, and supply needs.
References
- American Society for Quality (ASQ). Supplier Quality.
https://asq.org/quality-resources/supplier-quality - National Institute of Standards and Technology (NIST). Concurrent Engineering Through Product Data Standards.
https://www.nist.gov/publications/concurrent-engineering-through-product-data-standards - American Society for Quality (ASQ). The ASQ Supply Chain Management Primer.
https://asq.org/-/media/Images/gift/E1451-The-ASQ-Supply-Chain-Management-Primer.pdf